Goodwin’s Asia team earned notable recognition for its exceptional performance across key practice areas—Private Equity, M&A, Private Investment Funds, and Life Sciences—from Chambers Asia‑Pacific, Chambers Greater China Region, and The Legal 500 Asia Pacific.
The firm secured rankings across multiple jurisdictions, including Asia‑Pacific, China, Hong Kong SAR, Singapore, and India, with numerous Goodwin partners acknowledged as leading practitioners. This year’s results also reflect several elevated rankings and first‑time individual recognitions, reinforcing the team’s growing prominence and deepening expertise throughout the region.
Goodwin’s standout practice rankings in Chambers and Legal 500 for 2026 include:
Chambers Asia Pacific
- Corporate/M&A: Private Equity (Asia-Pacific)
- Investment Funds: Private Equity (Asia-Pacific)
- Corporate/M&A (India)
- Investment Funds: International (Singapore)
Chambers Greater China Region
The Legal 500 Asia Pacific
- Private Equity (Hong Kong)
- Private Equity (China)
- Corporate (including M&A) (Hong Kong)
- Investment Funds (Hong Kong)
- Investment Funds (Singapore)
Goodwin lawyers ranked by Chambers and/or Legal 500 include:
- Yash Rana – Corporate M&A (India), Private Equity: Buyout & Venture Capital Investment (China)
- Douglas Freeman – Private Equity: Buyout & Venture Capital Investment (China)
- Daniel Dusek – Corporate/M&A (China), Private Equity: Buyout & Venture Capital Investment (China), Private Equity (Hong Kong), Corporate (including M&A) (Hong Kong)
- Edwin Chan – Private Equity: Buyout & Venture Capital Investment (China)
- Gregory Barclay – Investment Funds: International (Singapore)
- Matthew Nortcliff – Investment Funds: International (Singapore), Investment Funds (Singapore)
- Manish Ranjan – Investment Funds: International (Singapore)
- Wendy Pan – Life Sciences (China)
The Goodwin Asia team received high praise from clients across the firm’s core practice areas, with sources noting that:
Private Equity / Corporate M&A – “They are always very strong at handling very complex situations. They focus on what really matters, but not at the expense of losing thoroughness.”
Investment Funds – “Goodwin has very experienced fund partners with in-depth knowledge of industry, trends and new developments.”
Life Sciences – “Goodwin is knowledgeable and diligent. It's always able to provide solutions to various situations and the feedback is timely.”
To view all of Goodwin’s 2026 rankings, visit Chambers Asia Pacific, Chambers Greater China Region, and The Legal 500 Asia Pacific.